Rudy JL: Differentiating between sensitivity and limit of detection. Clin Chem35:509, 1989
2.
Fraser CG, Lipworth BJ: More on analytical goals for theophylline assays. Clin Chem34:796-797, 1988
3.
McCoy HG, Labrosse KR, McBride JW: Digitalis, in Rothfeld B (ed): Nuclear Medicine, In Vitro (ed 2). Philadelphia, PA, Lippincott , 1983
4.
Ackerman BH, Berg HG, Strate RG, et al: Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serum. J Clin Microbiol18:994-995, 1983
5.
Goldstein A. , Aronow L., Kalman SM: Principles of Drug Action: The Basis of Pharmacology (ed 2). New York, NY, Wiley, 1974, pp xxx
6.
Kipiniak W.: A basic problem—The measurement of height and area. J ChromatogrSci19:332-337, 1981
7.
McCoy RW, Aiken RL, Pauls RE, et al: Results of a cooperative study comparing the precision of peak height and area measurements in liquid chromatography. J ChromatogrSci22:425-431, 1984
8.
Thoma JJ, Bondo PB, Kozak CM: Tricyclic antidepressants in serum by a Clin-Elut column extraction and high pressure liquid chromatographic analysis. Ther Drug Monit1:335-358, 1979
9.
Pinkerton TC : Analysis of drugs in biological fluids by direct injection onto IRSP columns. Am Clin Lab100:32-37, 1989
10.
Dolan JW: LC Troubleshooting, peak problems. LC-GC7:316-318, 1989
11.
Koziol TR, Jacob JT, Achari RG: Ion-pair liquid chromatographic assay of decongestants and antihistamines . J Pharm Sci68:1135-1138, 1979
12.
Farwell SO, Gage DR, Kagel RA: Current status of prominent selective gas chromatographic detectors: A critical assessment. J ChromatogrSci19:358-376, 1981
13.
Albani F., Riva R., Contin M., et al: Valproic acid binding to human serum albumin and human plasma: Effects of pH variation and buffer composition in equilibrium dialysis. Ther Drug Monit6:31-33, 1984
14.
Kurz H., Trunk H., Weitz B.: Evaluation of methods to determine protein-binding of drugs, equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration. Arzneim Forsch/Drug Res27:1373-1380, 1977
15.
Lane JR, Labrosse KR, McBride, et al: Albumin and alpha-1-acid-glycoprotein content of ultrafiltrate . Drug Intell Clin Pharm14:635, 1980
16.
Allison TH, Comstock TJ: Temperature dependence of phenytoin-protein binding in serum: Effects of uremia and hypoalbuminemia. Ther Drug Monit10:376-381, 1988
17.
Ebert SC, Leroy M., Darcey B.: Comparison of aminoglycoside concentrations measured in plasma versus serum . Ther Drug Monit11:44-46, 1989
18.
Hullet FJ, Levy AB, Tachiki KH: Serum imipramine concentrations lower than plasma values. J Clin Psychiatry45:516-518,1984
19.
Spina E., Ericsson O., Nordin C.: Analysis of tricyclic antidepressants in serum and plasma yields similar results . Ther Drug Monit7:242-243, 1985
20.
Chan K-M., Daft M., Koenig JW, et al: Plasma separator tube of Becton Dickinson evaluated. Clin Chem34:2158-2159, 1988
21.
Simonsen Llp : Top 200 drugs of 1987. Pharm Timesxx:38-46,1988
22.
Demorest DM : Distinguishing cyclobenzaprine from amitriptyline and imipramine by liquid chromatography with UV multi-wavelength or full-spectrum detection. Blood levels of cyclobenzaprine in emergency screens. J Anal Toxicol11:133-134,1987
23.
Puopolo PR, Flood JG: Detection of interference of cyclobenzaprine in liquid chromatographic assays of tricyclic antidepressants. Clin Chem33:819-820, 1987
24.
Tasset JJ, Schroeder TJ, Pesce AJ: Cyclobenzaprine overdose: The importance of a clinical history in analytical toxicology. J Anal Toxicol10:258, 1986
25.
Taylor EH, Eudy S., Pappas AA: False positive identification of a tricyclic antidepressant due to cyclobenzaprine (Flexeril). Clin Chem34:1262, 1988
26.
McCoy HG, Cipolle RJ, Ehlers SM, et al: Severe methanol poisoning: Application of a pharmacokinetic model for ethanol therapy and hemodialysis. Am J Med67:804-807, 1979
27.
Ehresman DJ , Price SM, Lakatua DJ: Screening biological samples for underivatized drugs using a splitless injection technique on fused silica capillary column gas chromatography. J Anal Toxicol9:55-62, 1985
28.
Chooi MK, Coates JE: Effect of use of specific monoclonal antibody on radioimmunoassay results for serum cyclosporine. Clin Chem34:2156, 1988
29.
Haven MC, Sobeski LM, Earl RA, et al: Cyclosporine concentrations in blood after liver transplantation: Correlation of immunoassay results with clinical events. Clin Chem35:564-568, 1989
Subbarao MN , Swanson JR, Mueggler PA: Cyclosporine determinations in heart and kidney transplant patients: Comparison of high-performance liquid chromatography, polyclonal, and monoclonal methods. Ther Drug Monit11:53-56, 1989
32.
Vernillet L. , Keller HP, Le Bigot JF, et al: Determination of cyclosporine in plasma: Specific radioimmunoassay with a monoclonal antibody and liquid chromatography compared. Clin Chem35:608-611, 1989
33.
Boyce EG, Lawson LA, Gibson GA, et al: Comparison of gentamicin immunoassays using univariate and multivariate analyses. Ther Drug Monit11:97-104, 1989
34.
Miller KW, Chan Kkh, McCoy HG, et al: Cephalothin kinetics: Before, during and after cardiopulmonary bypass surgery. Clin Pharmacol Ther26:54-62, 1979
35.
Miller KW, McCoy HG, Chan Kkh, et al: Effect of cardiopulmonary bypass on cefazolin disposition. Clin Pharmacol Ther27:550-556, 1980
36.
Dorey RC, Preskorn SH, Widener PK: Results compared for tricyclic antidepressants as assayed by liquid chromatography and enzyme immunoassay. Clin Chem34: 2348-2351, 1988
37.
Labrosse KR , McCoy HG: Reliability of antidepressants assays: A reference laboratory perspective on antidepressant monitoring. Clin Chem34:859-862, 1988
38.
Crothers DC : Interference of spironolactone metabolites in a digoxin radioimmunoassay. Ther Drug Monit11:113-114,1989
39.
Labrosse KR , Veit C., Frakes M., et al: Effect of electrolyte concentrations on the digoxin-quinidine interaction. Clin Chem27:1088, 1981
40.
Caliman NC, Natho Gjw, Fischer GA: Monitoring of serum free digoxin concentrations in Fab-treated patients . Clin Chem34:1250, 1988
41.
Jacobi J., McGory RW, McCoy HG, et al: Hemodialysis clearance of total and unbound lidocaine. Clin Pharm2:54-57, 1983
42.
McCoy HG, Labrosse KR, Lane JR, et al: Disopyramide plasma protein binding. Drug Intell Clin Pharm15:26, 1981
43.
Morganroth J., Anderson JL, Gentzkow GD: Classification of type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide. J Am Coll Cardiol8:607-615, 1986
44.
Roden DM, Woosley RL: Drug therapy, flecainide. N Engl J Med315:36-41, 1986
45.
McBride JW, McCoy HG, Goldenberg IF: Supraventricular tachycardia treated with continuous infusions of propranolol . Clin Pharmacol Ther44:93-99, 1988
46.
Wargin WA, Sawchuk RJ, McBride JW, et al: Variable first-pass metabolism of propranolol following single and multiple doses in hypertensive patients. Eur J Drug Metab Pharmacokinet7:183-189, 1982
47.
Kates RE, Harrison DC, Winkle RA: Metabolite cumulation during long-term oral encainide administration . Clin Pharmacol Ther31:427-432, 1982
48.
Weaver DF, Camfield P., Fraser A.: Massive carbamazepine overdose: Clinical and pharmacologic observations in five episodes. Neurology38:755-759, 1988
49.
McKauge L., Tyrer JH, Eadie MJ: Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma. Ther Drug Monit3:63-70, 1981
50.
Gordon RE, Hanley PE, Shaw D., et al: Localization of metabolites in animals using 31-P topical magnetic resonance. Nature287:736-738, 1980
51.
Fitzgerald RL, Ramos JM, Bogema SC, et al: Resolution of methamphetamine stereoisomers in urine drug testing: Urinary excretion of R(-)-methamphetamine following use of nasal inhalers. J Anal Toxicol12:255-259, 1988
52.
Kinter M., Shipe JR, Savory J.: Tandem mass spectrometry in drug-abuse testing, exemplified for anabolic steriods . Clin Chem34:2178, 1988
53.
Browne TR, Van Langenhove A, Costello CE, et al: Applications of stable isotope methods to studying the clinical pharmacology of antiepileptic drugs in newborns, infants, children, and adolescents . Ther Drug Monit6:3-9, 1984
54.
Kaye CM: The gas chromatographic analysis of drugs in biological fluids, in Progress in Drug Metabolism, vol 4. New York, NY, Wiley, 1980, chap 4
55.
Mabuchi H., Nakahashi H.: Liquid-chromatographic profiling of endogenous fluorescent substances in sera and urine of uremic and normal subjects. Clin Chem29:675-677, 1983
56.
Marks V., Mould GP, O'Sullivan MJ, et al: Monitoring of drug disposition by immunoassay, in Bridges JW, Chasseaud LF (eds): Progress in Drug Metabolism, Vol 5. New York, NY, Wiley , 1980, chap 4
57.
McCoy HG, Cipolle RJ: Optimizing drug therapy: Which patients and which drugs. Postgrad Med74:121-134, 1983
58.
Meffin PJ, Miners JO: The high-performance liquid chromatographic measurement of drugs in biological fluids, in Progress in Drug Metabolism, Vol 4. New York, NY, Wiley, 1980, chap 5
59.
Mould G., Marks V.: The use of solid-phase chemistry in therapeutic drug monitoring. Clin Pharmacokinet14:65-70, 1988
60.
Roden DM: Antiarrhythmic activity of the O-demethyl metabolite of encainide . J Pharmacol Exp Ther221:552-557, 1982
61.
St Louis PJ , MacDonald M., Giesbrecht E., et al: An evaluation of the Kodak Ektachem clinical chemistry slide for theophylline. Ther Drug Monit11:93-96, 1989
62.
Wei JS, Tsai CY, Huang HM, et al: The effect of Vitamin B2 and its derivatives on a dry-reagent strip theophylline assay. Ther Drug Monit11:84-87, 1989
63.
Wilson JF, Tsanaclis LM, Williams J., et al: Comparison of nonisotopic and radioimmunoassay techniques for digoxin: A study based on external quality assurance measurements. Ther Drug Monit11:477-479, 1989
64.
Chandler Mhh , Hughes JA, Clifton GD: Utility of rapid theophylline assay in clinical research. Ther Drug Monit11:365-367, 1989
65.
Fraser AD, Bryan W., Isner AF: Evaluation of the EMIT amitriptyline and nortriptyline assays for the determination of serum clomipramine and desmethylclomipramine. Ther Drug Monit11:349-353, 1989
66.
Miles MV, Howlett CM, Tennison MB, et al: Determination of N-desmethylmethsuximide serum concentrations using enzyme-multiplied and fluorescence polarization immunoassays. Ther Drug Monit11:337-342, 1989
67.
Giesbrecht EE, Soldin SJ, Wong PY: A rapid, reliable high-performance liquid chromatographic micromethod for the measurement of cyclosporine in whole blood . Ther Drug Monit11:332-336, 1989
68.
Hooks MA, Millikan WJ, Henderson JM, et al: Comparison of whole-blood cyclosporine levels measured by radioimmunoassay and fluorescent polarization in patients post othotopic liver transplant. Ther Drug Monit11:304-309, 1989
69.
Morse GD, Holdsworth MT, Walshe JJ: Comparison of cyclosporine assay methodology in the immediate postoperative period of renal transplantation. Ther Drug Monit11:238-245, 1989
70.
Cooper JK, Hawes EM, Hubbard JW, et al: An ultrasensitive method for the measurement of fluphenazine in plasma by high-performance liquid chromatography with coulometric detection . Ther Drug Monit11:354-360, 1989
71.
Kazierad DJ , Hoon TJ, Bottorff MB: A high-performance liquid chromatographic method for the determination of encainide and its major metabolites in urine and serum using solid-phase extraction. Ther Drug Monit11:327-331,1989
72.
Fraser CG: Acceptable analytical error: A different opinion. Clin Chem35:1553-1554, 1989
73.
Linnet K.: The between-run component of variation in internal quality control . Clin Chem35:1416-1422, 1989
74.
Johnston A. , Marsden JT, Holt DW: The continuing need for quality assessment of cyclosporine measurement. Clin Chem35:1309-1312, 1989
75.
Copeland KR , Yatscoff RW: Calibration problems with the 125-I immunoassay for measuring cyclosporine A. Clin Chem35:1551-1552, 1989
76.
Schmid R., Kupferschmidt R.: Strategies for sample preparation with use of solid-phase extraction of TDM of basic drugs. Clin Chem35:1352, 1989
77.
Gerhardt G. , Davitt C., Chan DW: Serum separator tube problems in Hitachi 736/737 analyzers. Clin Chem35:1554, 1989
78.
Shaw LM: Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring . Clin Chem35: 1229-1308, 1989
79.
Yeo K-T., Traverse W., Horowitz GL: Clinical performance of the EMIT vancomycin assay. Clin Chem35:1504-1507,1989
80.
Stone JA, Soldin SJ: An update on digoxin. Clin Chem35:1326-1331, 1989
81.
Bowers LD: High-performance liquid chromatography/mass spectrometry: State of the art for the drug analysis laboratory. Clin Chem35:1282-1287, 1989
82.
Gilpin RK, Pachla LA: Pharmaceuticals and related drugs. Anal Chem57:29R-46R, 1985
83.
Pleasants RA , Williams DM, Porter RS, et al: Reassessment of cross-reactivity of spironolactone metabolites with four digoxin immunoassays. Ther Drug Monit11:200-204, 1989
84.
Rainey PM: Digoxin immune Fab (Digibind) markedly affects the results of immunoassays for digoxin. Clin Chem35:1165, 1989
85.
Nuwayhid NF , Johnson GF: Elimination of total digoxin from a patient in chronic renal failure post Fab fragment (Digibind) therapy. Clin Chem35:1179, 1989 86. Goldsmith BM, Troyanskyl D., Hanges L.: Comparison of cyclosporine assays in pediatric patients receiving organ transplants. Clin Chem35:1168, 1989
